Literature DB >> 11399671

Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions.

S L Hansen1, B Ebert, B Fjalland, U Kristiansen.   

Abstract

Based on an unexpected high maximum response to piperidine-4-sulphonic acid (P4S) at human alpha1alpha6beta2gamma2 GABA(A) receptors expressed in Xenopus oocytes attempts to correlate this finding with the pharmacological profile of P4S and other GABA(A) receptor ligands in neuronal cultures from rat cerebellar granule cells and rat cerebral cortex were carried out. GABA and isoguvacine acted as full and piperidine-4-sulphonic acid (P4S) as partial agonists, respectively, at alpha1beta2gamma2, alpha6beta2gamma2 and alpha1alpha6beta2gamma2 GABA receptors expressed in Xenopus oocytes with differences in potency. Whole-cell patch-clamp recordings were used to investigate the pharmacological profile of the partial GABA(A) receptor agonists 4,5,6,7-tetrahydroisoxazolo-(5,4-c)pyridin-3-ol (THIP), P4S, 5-(4-piperidyl)isoxazol-3-ol (4-PIOL), and 3-(4-piperidyl)isoxazol-5-ol (iso-4-PIOL), and the competitive GABA(A) receptor antagonists Bicuculline Methbromide (BMB) and 2-(3-carboxypropyl)-3-amino-6-methoxyphenyl-pyridazinium bromide (SR95531) on cerebral cortical and cerebellar granule neurons. In agreement with findings in oocytes, GABA, isoguvacine and P4S showed similar pharmacological profiles in cultured cortical and cerebellar neurones, which are known to express mainly alpha1, alpha2, alpha3, and alpha5 containing receptors and alpha1, alpha6 and alpha1alpha6 containing receptors, respectively. 4-PIOL and iso-4-PIOL, which at GABA(A) receptors expressed in oocytes were weak antagonists, showed cell type dependent potency as inhibitors of GABA mediated responses. Thus, 4-PIOL was slightly more potent at cortical neurones than at granule neurones and iso-4-PIOL was more potent in inhibiting isoguvacine-evoked currents at cortical than at granule neurons. Furthermore the maximum response to 4-PIOL corresponded to that of a partial agonist, whereas that of iso-4-PIOL gave a maximum response close to zero. It is concluded that the pharmacological profile of partial agonists is highly dependent on the receptor composition, and that small structural changes of a ligand can alter the selectivity towards different subunit compositions. Moreover, this study shows that pharmacological actions determined in oocytes are generally in agreement with data obtained from cultured neurons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399671      PMCID: PMC1572819          DOI: 10.1038/sj.bjp.0704121

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  Stoichiometry of a recombinant GABAA receptor.

Authors:  Y Chang; R Wang; S Barot; D S Weiss
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

Review 2.  Which GABAA-receptor subtypes really occur in the brain?

Authors:  R M McKernan; P J Whiting
Journal:  Trends Neurosci       Date:  1996-04       Impact factor: 13.837

Review 3.  Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.

Authors:  W Sieghart
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

4.  GABA antagonists differentiate between recombinant GABAA/benzodiazepine receptor subtypes.

Authors:  H Lüddens; E R Korpi
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

Review 5.  Structure and pharmacology of vertebrate GABAA receptor subtypes.

Authors:  P J Whiting; R M McKernan; K A Wafford
Journal:  Int Rev Neurobiol       Date:  1995       Impact factor: 3.230

6.  Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor.

Authors:  E R Korpi; T Kuner; P H Seeburg; H Lüddens
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

7.  Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.

Authors:  B Ebert; K A Wafford; P J Whiting; P Krogsgaard-Larsen; J A Kemp
Journal:  Mol Pharmacol       Date:  1994-11       Impact factor: 4.436

8.  Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.

Authors:  N C Saxena; R L Macdonald
Journal:  Mol Pharmacol       Date:  1996-03       Impact factor: 4.436

9.  The low efficacy gamma-aminobutyric acid type A agonist 5-(4-piperidyl)isoxazol-3-ol opens brief Cl- channels in embryonic rat olfactory bulb neurons.

Authors:  U Kristiansen; J L Barker; R Serafini
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

10.  Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors.

Authors:  K L Hadingham; E M Garrett; K A Wafford; C Bain; R P Heavens; D J Sirinathsinghji; P J Whiting
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

View more
  5 in total

1.  Positioning of the alpha-subunit isoforms confers a functional signature to gamma-aminobutyric acid type A receptors.

Authors:  Frédéric Minier; Erwin Sigel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

2.  Characterization of GABA(A) receptor ligands in the rat cortical wedge preparation: evidence for action at extrasynaptic receptors?

Authors:  B Ebert; S i Storustovu; M Mortensen; B Frølund
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

3.  Temporal Regulation of GABAA Receptor Subunit Expression: Role in Synaptic and Extrasynaptic Communication in the Suprachiasmatic Nucleus.

Authors:  James C Walton; John K McNeill; Khallyl A Oliver; H Elliott Albers
Journal:  eNeuro       Date:  2017-05-01

Review 4.  Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy.

Authors:  Slobodan M Janković; Miralem Dješević; Snežana V Janković
Journal:  J Exp Pharmacol       Date:  2021-03-08

Review 5.  Electrophysiology of ionotropic GABA receptors.

Authors:  Erwan Sallard; Diane Letourneur; Pascal Legendre
Journal:  Cell Mol Life Sci       Date:  2021-06-01       Impact factor: 9.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.